AUPH Earnings Aurinia Pharmaceuticals Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.25 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 2.07 | 2026-02-26 | 10-K |
| FY 2025 | 2025-09-30 | 0.23 | 2026-02-26 | 10-K |
| FY 2025 | 2025-06-30 | 0.16 | 2026-02-26 | 10-K |
| Q1 2026 | 2025-03-31 | 0.16 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | 0.04 | 2026-02-26 | 10-K |
| FY 2025 | 2024-09-30 | 0.10 | 2026-02-26 | 10-K |
| FY 2025 | 2024-06-30 | 0.01 | 2026-02-26 | 10-K |
| FY 2025 | 2024-03-31 | -0.07 | 2026-02-26 | 10-K |
| FY 2025 | 2023-12-31 | -0.54 | 2026-02-26 | 10-K |
| FY 2024 | 2023-09-30 | -0.09 | 2025-02-27 | 10-K |
| FY 2024 | 2023-06-30 | -0.08 | 2025-02-27 | 10-K |
| FY 2024 | 2023-03-31 | -0.18 | 2025-02-27 | 10-K |
| FY 2024 | 2022-12-31 | -0.76 | 2025-02-27 | 10-K |
| FY 2023 | 2022-09-30 | -0.06 | 2024-02-15 | 10-K |
| FY 2023 | 2022-06-30 | -0.25 | 2024-02-15 | 10-K |
| FY 2023 | 2022-03-31 | -0.27 | 2024-02-15 | 10-K |
| FY 2023 | 2021-12-31 | -1.40 | 2024-02-15 | 10-K |
| FY 2022 | 2021-09-30 | -0.39 | 2023-02-28 | 10-K |
| FY 2022 | 2021-06-30 | -0.37 | 2023-02-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.